WHO adds LC16m8 mpox vaccine to Emergency Use Listing.

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's declaration of an mpox public health emergency of international concern (PHEIC) on 14 August 2024.This decision is expected to facilitate increased and timely access to vaccines in communities where mpox outbreaks are surging.In 2024, cases have been reported across 80 countries, including 19 countries in Africa, based on data as of 31 October 2024.The Democratic Republic of the Congo, the hardest-hit country, recorded a large majority of suspected cases -over 39 000 -as well as more than 1000 deaths.Today's move is particularly relevant as the Government of Japan has announced that it will donate 3.05 million doses of the LC16m8 vaccine, along with specialized inoculation needles, to the Democratic Republic of the Congo.This is the largest donation package announced to date in response to the current mpox emergency.